Compare Lustrum:ASKA Pharmaceutical Co.,Ltd.:4514

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index ASKA Pharmaceutical Co.,Ltd. Go to web site 4514 Medicals 1st TSE March 1, 2000 1955.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

ASKA Pharmaceutical Co.,Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ASKA Pharmaceutical Co.,Ltd. Balance Sheet 2020年3月期 ASKA Pharmaceutical Co.,Ltd. Balance Sheet 2019年3月期 ASKA Pharmaceutical Co.,Ltd. Balance Sheet 2018年3月期 ASKA Pharmaceutical Co.,Ltd. Balance Sheet 2017年3月期 ASKA Pharmaceutical Co.,Ltd. Balance Sheet 2016年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2020 March 31, 2019 March 31, 2018 March 31, 2017 March 31, 2016
Cash and Cash Equivalents
(Percent)
7,294down
(9.1%)down
10,982up
(13.4%)down
10,221down
(15.4%)down
14,761up
(22.3%)up
5,462
(9.5%)
Other Current AssetsHelp
(Percent)
30,032up
(37.4%)up
26,847up
(32.7%)down
24,597up
(37.1%)up
22,298up
(33.7%)down
21,416
(37.3%)
Tangible Fixed AssetsHelp
(Percent)
13,539down
(16.9%)up
13,573up
(16.5%)down
12,129down
(18.3%)down
12,829down
(19.4%)down
13,801
(24.0%)
Intangible Fixed AssetHelp
(Percent)
9,368down
(11.7%)down
9,598up
(11.7%)up
1,140down
(1.7%)down
3,491up
(5.3%)up
368
(0.6%)
Investments and OthersHelp
(Percent)
20,006down
(24.9%)down
21,194up
(25.8%)up
13,932up
(21.0%)up
7,013down
(10.6%)down
14,212
(24.7%)
Total AssetsHelp
(Percent)
80,239
(100%)
82,194
(100%)
66,235
(100%)
66,126
(100%)
57,478
(100%)
Total Current LiabilitiesHelp
(Percent)
24,995down
(31.2%)down
25,768up
(31.4%)down
21,926down
(33.1%)down
24,115up
(36.5%)up
18,267
(31.8%)
Total Long-term LiabilitiesHelp
(Percent)
13,671up
(17.0%)up
12,970up
(15.8%)up
1,750down
(2.6%)down
2,500down
(3.8%)down
3,250
(5.7%)
Shareholder's EquityHelp
(Percent)
41,573down
(51.8%)down
43,456up
(52.9%)down
42,559up
(64.3%)up
39,511up
(59.8%)down
35,961
(62.6%)
Total LiabilitiesHelp
(Percent)
80,239
(100%)
82,194
(100%)
66,235
(100%)
66,126
(100%)
57,478
(100%)

ASKA Pharmaceutical Co.,Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ASKA Pharmaceutical Co.,Ltd. Profit and Loss Account 2020年3月期 ASKA Pharmaceutical Co.,Ltd. Profit and Loss Account 2019年3月期 ASKA Pharmaceutical Co.,Ltd. Profit and Loss Account 2018年3月期 ASKA Pharmaceutical Co.,Ltd. Profit and Loss Account 2017年3月期 ASKA Pharmaceutical Co.,Ltd. Profit and Loss Account 2016年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2020 March 31, 2019 March 31, 2018 March 31, 2017 March 31, 2016
Amount of Sales
(Percent)
52,542
(100%)
46,706
(100%)
48,944
(100%)
48,527
(100%)
43,215
(100%)
Total Sales
(Percent)
52,542
(100%)
46,706
(100%)
48,944
(100%)
48,527
(100%)
43,215
(100%)
Cost of SalesHelp
(Percent)
28,525up
(54.3%)down
27,814down
(59.6%)down
30,059up
(61.4%)up
29,614up
(61.0%)up
26,072
(60.3%)
Other Costs and RevenueHelp 23,368up
(44.5%)up
17,148up
(36.7%)up
16,497up
(33.7%)up
15,969down
(32.9%)down
16,441
(38.0%)
Total CostsHelp 51,893 44,962 46,556 45,583 42,513
Net RevenueHelp 24,017up
(45.7%)up
18,892up
(40.4%)up
18,885down
(38.6%)down
18,913up
(39.0%)down
17,143
(39.7%)
Earnings Before TaxHelp 901down
(1.7%)down
1,883down
(4.0%)down
3,063down
(6.3%)down
3,300up
(6.8%)up
1,448
(3.4%)
Net IncomeHelp 649down
(1.2%)down
1,744down
(3.7%)down
2,388down
(4.9%)down
2,944up
(6.1%)up
702
(1.6%)
当期純利益 649 1,744 2,388 2,944 702

ASKA Pharmaceutical Co.,Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ASKA Pharmaceutical Co.,Ltd. Cash Flow Statement 2020年3月期 ASKA Pharmaceutical Co.,Ltd. Cash Flow Statement 2019年3月期 ASKA Pharmaceutical Co.,Ltd. Cash Flow Statement 2018年3月期 ASKA Pharmaceutical Co.,Ltd. Cash Flow Statement 2017年3月期 ASKA Pharmaceutical Co.,Ltd. Cash Flow Statement 2016年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2020 March 31, 2019 March 31, 2018 March 31, 2017 March 31, 2016
Operating Cash Flow(OFC)Help
(Percent)
-493down
(-12.9%)down
2,504up
(16.1%)up
75down
(1.7%)down
12,061up
(100.0%)up
-1,349
(-16.6%)
Investing Cash Flow(ICF)Help
(Percent)
-2,927up
(-76.8%)up
-14,780down
(-95.1%)down
-3,348down
(-74.6%)down
-378up
(-3.1%)up
-6,776
(-83.4%)
Financing Cash FlowHelp
(Percent)
-392down
(-10.3%)down
13,036up
(83.9%)up
-1,142up
(-25.4%)down
-2,384down
(-19.8%)down
4,013
(49.4%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
0
-
0
-
0
-
0
-
0
-
Net Increase and Decrease in Cash and Cash Equivalentsn -3,812down
(-100.0%)down
760up
(4.9%)up
-4,415down
(-98.3%)down
9,299up
(77.1%)up
-4,112
(-50.6%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

ASKA Pharmaceutical Co.,Ltd.

Company where related level is highHelp

Kubota Pharmaceutical Holdings Co.,Ltd.
Fuso Pharmaceutical Industries, Ltd.
StemRIM Inc.
Otsuka Holdings Co.,Ltd.
TAISHO PHARMACEUTICAL CO.,LTD.
Carna Biosciences,Inc.
ECI,Inc.
CanBas Co.,Ltd.
TAIKO PHARMACEUTICAL CO.,LTD.
MediciNova,Inc